KURE
KraneShares MSCI All China Hlth Care ETF
MSCI China All Shares HC 10/40 NR USD
NAV as of
4 Week: 19.37 - 21.02
52 Week: 16.79 - 24.75
Latest Closing Price
19.68
Premium / Discount
0.38
Expense Ratio
0.65%
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -7.99 | 1.65 | -4.83 |
| 1 Day | 1.60 | 0.00 | 0.00 |
| 1 Week | -0.91 | 4.81 | -0.19 |
| 1 Month | -3.34 | 7.56 | -0.44 |
| 3 Months | -7.13 | 13.04 | -0.55 |
| 6 Months | 1.18 | 19.69 | 0.06 |
| 1 Year | 1.55 | 32.57 | 0.05 |
| 2 Years | -55.99 | 51.03 | -1.10 |
| 3 Years | -28.02 | 60.48 | -0.46 |
| 5 Years | -34.81 | 77.72 | -0.45 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 34.0314 | 67.2826 | -15.8569 | -25.3908 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 29.0000 | 9.0000 | 70.0000 | 46.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 87
Number of Bond Holdings: 0
Number of Equity Holdings: 85
Total Market Value: 83,791,533
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | WuXi Biologics (Cayman) Inc | 8.2391 | 1,165,135 | 0 | 14,662,923 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 36.25 |
| Large | 52.64 |
| Medium | 8.82 |
| Small | 2.13 |
| Micro | 0.00 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
21.1046
Price/Book*
3.2174
Price/Sales*
2.0596
Price/Cash Flow*
12.4969
Dividend Yield*
1.2659
Growth Measures
Long-Term Earnings
17.4378
Historical Earnings
20.4055
Sales Growth
8.6989
Cash-Flow Growth
0.9747
Book-Value Growth
11.2453
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
